Total Payments
$2,574
2024 Payments
$856.48
Companies
32
Transactions
79
Medicare Patients
1,355
Medicare Billing
$247,537
Payment Breakdown by Category
Food & Beverage$1,945 (75.6%)
Education$628.44 (24.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,945 | 66 | 75.6% |
| Education | $628.44 | 13 | 24.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $314.75 | 17 | $0 (2024) |
| Janssen Biotech, Inc. | $275.97 | 3 | $0 (2023) |
| Amgen Inc. | $252.31 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $189.83 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $135.60 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $130.00 | 6 | $0 (2024) |
| Lilly USA, LLC | $114.63 | 2 | $0 (2017) |
| INSYS Therapeutics Inc | $111.97 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $109.82 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $100.56 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $856.48 | 33 | PFIZER INC. ($180.96) |
| 2023 | $357.35 | 13 | PFIZER INC. ($111.79) |
| 2022 | $211.43 | 5 | AstraZeneca Pharmaceuticals LP ($109.82) |
| 2021 | $275.23 | 6 | Amgen Inc. ($121.38) |
| 2020 | $67.09 | 4 | Astellas Pharma US Inc ($24.57) |
| 2019 | $351.91 | 8 | E.R. Squibb & Sons, L.L.C. ($116.15) |
| 2018 | $55.17 | 4 | Seattle Genetics, Inc. ($24.58) |
| 2017 | $399.18 | 6 | Lilly USA, LLC ($114.63) |
All Payment Transactions
79 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $24.51 | General |
| Category: Hematology/Oncology | ||||||
| 11/19/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $23.11 | General |
| Category: Hematology | ||||||
| 11/12/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/08/2024 | ARRAY BIOPHARMA INC | IBRANCE (Drug), LORBRENA, BRAFTOVI | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Oncology | ||||||
| 09/16/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: Oncology | ||||||
| 08/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.34 | General |
| 08/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/30/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 07/24/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: ONCOLOGY | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Oncology | ||||||
| 07/09/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Oncology | ||||||
| 07/01/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $21.91 | General |
| 06/27/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $1.63 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $20.15 | General |
| 06/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Oncology | ||||||
| 05/30/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 05/27/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Oncology | ||||||
| 05/24/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: HEMATOLOGY | ||||||
| 05/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Oncology | ||||||
| 05/06/2024 | SOBI, INC | DOPTELET (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/26/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Oncology | ||||||
| 03/20/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Oncology | ||||||
| 03/12/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 297 | 805 | $111,891 | $59,402 |
| 2022 | 3 | 320 | 825 | $117,945 | $62,118 |
| 2021 | 6 | 388 | 968 | $132,166 | $72,817 |
| 2020 | 5 | 350 | 881 | $117,119 | $53,200 |
Total Patients
1,355
Total Services
3,479
Medicare Billing
$247,537
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 255 | 747 | $102,195 | $53,956 | 52.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 46 | $8,556 | $4,811 | 56.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $1,140 | $634.92 | 55.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 269 | 753 | $104,505 | $54,180 | 51.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 39 | 60 | $11,160 | $6,712 | 60.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,280 | $1,226 | 53.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 276 | 750 | $99,018 | $56,312 | 56.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 43 | 66 | $12,576 | $7,420 | 59.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 93 | $13,764 | $5,455 | 39.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $2,880 | $1,836 | 63.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 23 | 24 | $2,088 | $1,105 | 52.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 13 | 23 | $1,840 | $688.60 | 37.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 261 | 706 | $88,488 | $40,505 | 45.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 47 | 78 | $14,658 | $6,735 | 45.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 20 | 73 | $10,804 | $4,324 | 40.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $2,090 | $1,080 | 51.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 13 | $1,079 | $555.85 | 51.5% |
About Dr. Jayne Gurtler, MD
Dr. Jayne Gurtler, MD is a Hematology & Oncology healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396712808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jayne Gurtler, MD has received a total of $2,574 in payments from pharmaceutical and medical device companies, with $856.48 received in 2024. These payments were reported across 79 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($1,945).
As a Medicare-enrolled provider, Gurtler has provided services to 1,355 Medicare beneficiaries, totaling 3,479 services with total Medicare billing of $247,537. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Metairie, LA
- Active Since 03/02/2006
- Last Updated 04/03/2009
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1396712808
Products in Payments
- ERLEADA (Drug) $199.98
- IBRANCE (Drug) $150.62
- BOSULIF (Drug) $142.56
- LUMAKRAS (Drug) $121.38
- EMPLICITI (Biological) $116.15
- SUBSYS (Drug) $111.97
- IMFINZI (Biological) $109.82
- KEYTRUDA (Biological) $100.56
- DOPTELET (Drug) $99.99
- Cabometyx (Drug) $79.47
- Erleada (Drug) $75.99
- MEKINIST (Drug) $67.08
- Nubeqa (Drug) $61.30
- Xtandi (Drug) $51.18
- Vonjo (Drug) $50.07
- BRUKINSA (Drug) $44.73
- XTANDI (Drug) $44.65
- EPKINLY (Drug) $39.80
- SARCLISA (Biological) $35.22
- KISQALI (Drug) $32.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Metairie
Rachel Caldwell, Md, MD
Hematology & Oncology — Payments: $5,717
Hematology & Oncology $5,717
Carrie Marquette, M.d, M.D
Hematology & Oncology — Payments: $4,503
Hematology & Oncology $4,503
Marcus Black, Md, MD
Hematology & Oncology — Payments: $3,693
Hematology & Oncology $3,693
Thomas Cosgriff, Md, MD
Hematology & Oncology — Payments: $2,551
Hematology & Oncology $2,551
Angelo Russo, Md, MD
Hematology & Oncology — Payments: $116.15
Hematology & Oncology $116.15
Laura Brinz, Md, MD
Hematology & Oncology — Payments: $79.47
Hematology & Oncology $79.47